By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Gallus Biopharmaceuticals, LLC 

4766 LaGuardia Drive

St. Louis  Missouri  63134  U.S.A.
Phone: 314-426-5000 Fax: 314-426-1792


SEARCH JOBS
Gallus BioPharmaceuticals has recently emerged on the market as a premier cGMP biologics contract manufacturing organization based in St. Louis, MO USA. Gallus operates an FDA-approved, commercial facility formerly owned by Centocor Biologics. The plant has been approved by every major regulatory agency and currently manufactures two of Centocor Biologics’ leading products, Remicade® and Stelara™, which are distributed globally. The Gallus facility has capabilities for clinical and commercial mammalian cell culture in batch, fed-batch and perfusion as well as process development and analytical services. Gallus’ business model incorporates the idea of virtual ownership of a dedicated suite, or “condominium” approach to biomanufacturing, along with the traditional pay-per-run or “timeshare” contract manufacturing. This novel approach provides clients with complete flexibility in accessing capacity as needed. This flexibility has been further enhanced under the partnership with Xcellerex and the turnkey XcellerexFlexFactory® cGMP manufacturing platform.

Facility and cGMP Manufacture
The Gallus facility has over 30,000 square feet of laboratory space for process development and clinical and commercial cGMP manufacture of mammalian cell culture-based biotherapeutics. The Clinical Services Suite (CSS) is a full-service cGMP production suite designed with a high degree of flexibility utilizing state-of-the-art disposable and scalable equipment for the production of Phase I / II and III(pre-process validation) clinical material. The Gallus commercial facility has four suites, from 500L to 2000L bioreactor scale. The facility can accommodate up to 4 future "condo" suites which will have cell culture fermentation at 2000L with room for up to 4 bioreactors per suite for a total of 8000L, along with appropriate scale downstream operations. All suites are designed for flexibility to utilize portable equipment, and can be easily reconfigured to meet a customer’s specific needs. There is also an ISO 7 classified suite for cGMP Cell Bank manufacture and for small cGMP fill finish activities.

Process and Analytical Development
The Gallus process development laboratories are designed to support development, technical transfer, and optimization of processes and analytical methods for clinical and commercial production. The group has considerable capabilities with a variety of host cell types and manufacturing processes and experience with multiple tech transfers, process optimization and development for many projects.

Gallus Culture
Gallus was created with the goal of taking a high quality, high performing team with a storied history of developing and producing biopharmaceuticals, and infusing this team with an entrepreneurial vision to build a world-class Contract Manufacturing Organization. To learn more about Gallus, please visit our website at www.gallusbiopharma.com.


Key Statistics


Email:
Ownership: Private

Web Site: Gallus Biopharmaceuticals, LLC
Employees:
Symbol: 
 




Segment
Pharmaceuticals





Company News
Gallus Biopharmaceuticals, LLC And GE Healthcare Life Sciences Named As Finalists For Global Bioprocessing Industry Award 10/3/2014 9:40:48 AM
TAP Biosystems And Gallus Biopharmaceuticals, LLC Co-Host FREE Webinar On Accelerating Biosimilar Process Development Explaining The Benefits Of Using ambr15 Microbioreactors For DoE 9/30/2014 12:42:23 PM
DPx Holdings B.V. Reaches Definitive Agreement To Acquire Gallus Biopharmaceuticals, LLC 8/27/2014 8:35:45 AM
Gallus Biopharmaceuticals, LLC Enters Agreement With Progenics Pharmaceuticals, Inc. (PGNX) For Manufacture Of Anti-PSMA Monoclonal Antibody 8/21/2014 10:33:53 AM
Gallus Biopharmaceuticals, LLC Utilises ambr15 Micro Bioreactor 4/29/2014 12:08:45 PM
Gallus Biopharmaceuticals, LLC Enters Cell Line Optimization And Manufacturing Agreement With Omni Bio Pharmaceutical 4/29/2014 11:17:54 AM
Gallus Biopharmaceuticals, LLC Strengthens Biologics CMO Business With Acquisition of Laureate Biopharmaceutical Services, Inc. 10/1/2013 9:55:13 AM
Gallus Biopharmaceuticals, LLC Presents Real World Data From Its "Factory of the Future" -- Future Manufacturing Available Today 4/22/2013 11:07:04 AM
Refine Technology and Gallus Biopharmaceuticals, LLC to Collaborate on Continuous BioManufacturing 1/22/2013 11:03:51 AM
Gallus Biopharmaceuticals, LLC and Roslin Cells Announce an Exclusive Partnership to Supply Cell Therapies for Clients 9/18/2012 10:03:11 AM
12
//-->